Leptin and Leptin receptor polymorphisms, plasma Leptin levels and obesity in Tunisian volunteers

被引:28
作者
Nesrine, Zayani [1 ]
Haithem, Hamdouni [1 ]
Imen, Boumaiza [1 ]
Fadoua, Neffati [2 ]
Asma, Omezzine [1 ]
Fadhel, Najjar Mohamed [2 ]
Ali, Bouslama [1 ]
机构
[1] Sahloul Univ Hosp, Biochem Dept, LR12SP11, Sousse, Tunisia
[2] Monastirs Univ Hosp, Lab Biochem & Toxicol, Monastir, Tunisia
关键词
Leptin levels; LEP; LEPR; obesity; Tunisian volunteers; BODY-MASS INDEX; GENE POLYMORPHISMS; SERUM LEPTIN; INSULIN-RESISTANCE; METABOLIC SYNDROME; DIABETES-MELLITUS; ASSOCIATION; WEIGHT; RISK; OB;
D O I
10.1111/iep.12271
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Adipose tissue is an important endocrine organ that secretes a number of adipokines, like Leptin (LEP). The aim this study was to investigate the prevalence of single nucleotide polymorphisms in LEP gene (LEP 3UTR A/C, -2548G/A) and LEPR (K109R and Q223R) and their association with Leptin level and obesity. We recruited 169 non-obese (body mass index [BMI]=24.51-3.69kg/m(2)) and 160 obese (BMI=36-4.78kg/m(2)) patients. Genotyping was performed using polymerase chain reaction-restriction fragment length polymorphism, BMI was calculated, and Leptin level was measured by ELISA. Statistical analyses were performed by spss19.0. According to LEP 3UTR A/C polymorphism, AC and CC genotype carriers had higher Leptin levels than AA genotype carriers, respectively, 31[0.05-148.8] (P=.008) vs 41[0.05-111.6] (P=.003). The K109R polymorphism was associated with obesity (P=.025) and seems to significantly decrease the LEP levels (P<.001). Concerning LEP G2548A polymorphism, our results showed that the OR of obesity associated with 2548 AA/GG was 1.87[1.106-2.78] P=.028 vs 1.41[1.035-1.85] P=.045 for 223AA/GG polymorphism. In our haplotype analysis, one haplotype seems to be the more protective and one other seems to be the highest risk to obesity. LEP 3UTR A/C and LEPR K109R polymorphisms were associated with Leptin level and obesity.
引用
收藏
页码:121 / 130
页数:10
相关论文
共 72 条
[1]   Leptin signaling [J].
Ahima, RS ;
Osei, SY .
PHYSIOLOGY & BEHAVIOR, 2004, 81 (02) :223-241
[2]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[3]  
2-S
[4]   Leptin as a Mediator of Obesity-Induced Hypertension [J].
Bell, Balyssa B. ;
Rahmouni, Kamal .
CURRENT OBESITY REPORTS, 2016, 5 (04) :397-404
[5]   Identification of a placental enhancer for the human leptin gene [J].
Bi, S ;
Gavrilova, O ;
Gong, DW ;
Mason, MM ;
Reitman, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (48) :30583-30588
[6]   Relationship Between Leptin G2548A and Leptin Receptor Q223R Gene Polymorphisms and Obesity and Metabolic Syndrome Risk in Tunisian Volunteers [J].
Boumaiza, Imen ;
Omezzine, Asma ;
Rejeb, Jihene ;
Rebhi, Lamia ;
Ouedrani, Amani ;
Ben Rejeb, Nabila ;
Nabli, Naoufel ;
Ben Abdelaziz, Ahmed ;
Bouslama, Ali .
GENETIC TESTING AND MOLECULAR BIOMARKERS, 2012, 16 (07) :726-733
[7]   The relation of leptin and soluble leptin receptor levels with metabolic and clinical parameters in obese and healthy children [J].
Catli, Gonul ;
Anik, Ahmet ;
Tuhan, Hale Unver ;
Kume, Tuncay ;
Bober, Ece ;
Abaci, Ayhan .
PEPTIDES, 2014, 56 :72-76
[8]   Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J].
Chobanian, AV ;
Bakris, GL ;
Black, HR ;
Cushman, WC ;
Green, LA ;
Izzo, JL ;
Jones, DW ;
Materson, BJ ;
Oparil, S ;
Wright, JT ;
Roccella, EJ .
HYPERTENSION, 2003, 42 (06) :1206-1252
[9]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[10]   The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations - Distinct metabolic effects of two fat compartments [J].
Cnop, M ;
Landchild, MJ ;
Vidal, J ;
Havel, PJ ;
Knowles, NG ;
Carr, DR ;
Wang, F ;
Hall, RL ;
Boyko, EJ ;
Retzlaff, BM ;
Walden, CE ;
Knopp, RH ;
Kahn, SE .
DIABETES, 2002, 51 (04) :1005-1015